Gujarat Themis Biosyn appoints director
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
Gujarat Themis Biosyn Ltd. appointed Namjin Park as an additional director of the Indian drugmaker.
Park will be representing Yuhan Corp. on the board. He has been working with Yuhan Corp. since 1994 and was designated as executive director in April.
Hinesh Doshi will be an alternate director to Park. He is a senior partner at Hinesh R. Doshi and Co LLP.
